BS
MRNA icon

Boenning & Scattergood’s Moderna MRNA Stock Holding History

Boenning & Scattergood’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$307K Buy
+1,785
New +$292K 0.05% 317
2022
Q3 		– Sell
-1,785
Closed -$255K – 379
2022
Q2 		$255K Hold
1,785
– – 0.05% 321
2022
Q1 		$307K Hold
1,785
– – 0.05% 317
2021
Q4 		$453K Buy
1,785
+505
+39% +$148K 0.07% 261
2021
Q3 		$492K Hold
1,280
– – 0.09% 242
2021
Q2 		$301K Buy
+1,280
New +$229K 0.05% 305

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boenning & Scattergood's MRNA Position: Q4 2022 in Review

Boenning & Scattergood opened a new position in Moderna (MRNA) in Q4 2022: 1,785 shares worth $307K. The stake represents 0.05% of the portfolio and ranks #317 among its holdings. This is a return to the name: Boenning & Scattergood previously reported a position in MRNA as recently as Q2 2022.

Boenning & Scattergood first reported a position in MRNA in Q2 2021 and has held it in 6 quarters since. The position peaked at $492K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Boenning & Scattergood held 1,785 shares of Moderna worth $307K as of Q4 2022.
  • Moderna was a new Boenning & Scattergood position in Q4 2022.
  • Moderna made up 0.05% of Boenning & Scattergood's portfolio in Q4 2022, its #317 holding.
  • Boenning & Scattergood first reported a position in Moderna in Q2 2021 and has held it in 6 quarters since.
  • Boenning & Scattergood's Moderna position peaked at $492K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.